Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we will assume that you are happy to receive all cookies and you will not see this message again. Click 'Find out more' for information on how to change your cookie settings.

In recent years our understanding of Parkinson's disease has expanded both in terms of pathological hallmarks as well as relevant genetic influences. In parallel with the aetiological discoveries a multitude of PD animal models have been established. The vast majority of these are rodent models based on environmental, genetic and mechanistic insight. A major challenge in many of these models is their ability to only recapitulate some of the complex disease features seen in humans. Although symptom alleviation and clinical signs are of utmost importance in therapeutic research many of these models lack comprehensive behavioural testing. While non-motor symptoms become increasingly important as early diagnostic markers in PD, they are poorly characterized in rodents. In this review we look at well-established and more recent animal models of PD in terms of behavioural characterization and discuss how they can best contribute to progression in Parkinson's research.

Original publication

DOI

10.1016/j.bbr.2017.10.021

Type

Journal article

Journal

Behav Brain Res

Publication Date

24/10/2017

Keywords

6-OHDA, ATP13A2, Alpha-synuclein, Animal models, DJ-1, FBXO7, GBA, LRRK2, MPTP, PINK1, Parkin, Parkinson's disease, Rodent behaviour, Rodent models, Rotenone, VPS35